An underground economy for unlicensed weight-loss drugs is propelled by TikTok fitness influencers and vendors on messaging platforms, according to new investigations.
Investigational Drug Acquiring Traction Online
The experimental drug, which remains in research studies, is being advertised by online personalities for its supposed fat-burning properties. Followers are encouraged to contact these profiles directly for supplier links, while also receiving promotional offers.
Thriving Trade on Social Networks
Additionally, a robust trade exists on Telegram, where communities with thousands of members share comparison photos, administration instructions and assertions of next-day British shipping. Sellers market the substance there before directing customers to other platforms for purchases.
Learning About The Experimental Drug
This medication is an experimental injection developed by US drugmaker Eli Lilly. The treatment targets three intestinal hormones – glucagon-like peptide-1, GIP and glucagon. Early trials suggest it could help individuals lose up to a quarter of their total weight. Referred to as the “triple G”, the substance is being hailed online as the next Ozempic.
Medical Professionals Express Worries
However, doctors and pharmacists have warned that the sale of what is still an unapproved drug in the UK is a cause for concern and could lead to users administering products of uncertain source.
Some experts stated the demand for the experimental drug could be linked to the increasing price of licensed slimming treatments such as Mounjaro.
Legal Status and Enforcement
Marketing the unapproved drug on TikTok or messaging apps is illegal in the UK, as it is an unapproved medication that cannot be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.
Several content creators try to circumvent the rules by referring to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted substance, but promotion and supply can still breach pharmaceutical, advertising, and customer regulations, potentially leading to penalties, legal action or imprisonment.
Platform Reaction and Content Removal
According to TikTok, the service has removed problematic content and prohibited related hashtags and search suggestions. The organization stated it was dedicated to keeping the service safe and investing in enhancing enforcement strategies.
Digital Trading Operations
Investigations also found communities with up to nine thousand members selling retatrutide using the platform's integrated discovery tool, which functions like a online catalog. Typing “retatrutide” immediately displays groups with numerous of users, filled with photos of weight loss, glowing reviews and step-by-step instructions for preparing or injecting at home.
After moments of entering one community, a vendor posted WhatsApp details, where the majority of purchases take place. The vendor sent an instruction manual and promised shipping within 48 hours. When asked whether the substance was authentic, one seller said: “You can’t be sure.” Another shared a photo of a alleged testing documentation. None inquired about weight, medical conditions or past usage.
Item Information and Costs
Inside these groups, posts show black plastic parcels with postal service stickers, stating to contain new batches. One communication read: “It took eight of us to load them this morning.”
Buyers can select between powder vials, mixed at home with sterile water, or ready-to-use pens usually priced at £160 for 20mg. When asked how long a pen should be used, vendors give conflicting answers varying between a several days to “depends on your body”.
Service Moderation and Security Measures
A representative for the messaging service said it actively monitored harmful content on its platform including content that encouraged the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.
Healthcare Professional Warnings
“People are injecting substances they cannot confirm. Although the science behind this drug is valid, these digital versions may not contain what they advertise,” stated Jason Murphy, the director of pharmacy at Chemist4U.
Dr Crystal Wyllie of Asda Online Doctor connected the increase in demand to recent cost increases for authorized weight-loss medications such as Mounjaro. “With prices increasing, patients are using social media. But fake treatments are highly risky. You can’t be certain what’s inside or whether the conditions they were made in was clean,” she explained.
Her staff has already seen patients injured by self-injection from unverified suppliers. “We recognize the disappointment, but purchasing from messaging apps or communication platforms is gambling with your health,” said the doctor. “These substances could be impure or improperly measured.”
Manufacturer Position
A spokesperson from the pharmaceutical company said retatrutide was in phase 3 clinical trials and had not been evaluated or authorized by any government authority anywhere in the world. “Therefore at this point no one can sell [it] for human use,” they explained, adding that any item “falsely representing itself as a company experimental substance not yet approved … may expose patients to potentially significant health risks”.
